Online citations, reference lists, and bibliographies.

Genetic Variants Influencing Elevated Myeloperoxidase Levels Increase Risk Of Stroke

Chia-Ling Phuah, T. Dave, R. Malik, M. Raffeld, A. Ayres, J. Goldstein, A. Viswanathan, S. Greenberg, J. Jagiełła, B. Hansen, B. Norrving, J. Jiménez‐Conde, J. Roquer, A. Pichler, C. Enzinger, J. Montaner, I. Fernández-Cadenas, A. Lindgren, A. Słowik, R. Schmidt, A. Biffi, N. Rost, C. Langefeld, H. Markus, B. Mitchell, B. B. Worrall, S. Kittner, D. Woo, M. Dichgans, J. Rosand, C. Anderson
Published 2017 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Primary intracerebral haemorrhage and lacunar ischaemic stroke are acute manifestations of progressive cerebral microvascular disease. Current paradigms suggest atherosclerosis is a chronic, dynamic, inflammatory condition precipitated in response to endothelial injury from various environmental challenges. Myeloperoxidase plays a central role in initiation and progression of vascular inflammation, but prior studies linking myeloperoxidase with stroke risk have been inconclusive. We hypothesized that genetic determinants of myeloperoxidase levels influence the development of vascular instability, leading to increased primary intracerebral haemorrhage and lacunar stroke risk. We used a discovery cohort of 1409 primary intracerebral haemorrhage cases and 1624 controls from three studies, an extension cohort of 12 577 ischaemic stroke cases and 25 643 controls from NINDS-SiGN, and a validation cohort of 10 307 ischaemic stroke cases and 29 326 controls from METASTROKE Consortium with genome-wide genotyping to test this hypothesis. A genetic risk score reflecting elevated myeloperoxidase levels was constructed from 15 common single nucleotide polymorphisms identified from prior genome-wide studies of circulating myeloperoxidase levels (P < 5 × 10-6). This genetic risk score was used as the independent variable in multivariable regression models for association with primary intracerebral haemorrhage and ischaemic stroke subtypes. We used fixed effects meta-analyses to pool estimates across studies. We also used Cox regression models in a prospective cohort of 174 primary intracerebral haemorrhage survivors for association with intracerebral haemorrhage recurrence. We present effects of myeloperoxidase elevating single nucleotide polymorphisms on stroke risk per risk allele, corresponding to a one allele increase in the myeloperoxidase increasing genetic risk score. Genetic determinants of elevated circulating myeloperoxidase levels were associated with both primary intracerebral haemorrhage risk (odds ratio, 1.07, P = 0.04) and recurrent intracerebral haemorrhage risk (hazards ratio, 1.45, P = 0.006). In analysis of ischaemic stroke subtypes, the myeloperoxidase increasing genetic risk score was strongly associated with lacunar subtype only (odds ratio, 1.05, P = 0.0012). These results, demonstrating that common genetic variants that increase myeloperoxidase levels increase risk of primary intracerebral haemorrhage and lacunar stroke, directly implicate the myeloperoxidase pathway in the pathogenesis of cerebral small vessel disease. Because genetic variants are not influenced by environmental exposures, these results provide new support for a causal rather than bystander role for myeloperoxidase in the progression of cerebrovascular disease. Furthermore, these results support a rationale for chronic inflammation as a potential modifiable stroke risk mechanism, and suggest that immune-targeted therapies could be useful for treatment and prevention of cerebrovascular disease.
This paper references
Genetic insights into common pathways and complex relationships among immune-mediated diseases
Miles Parkes (2013)
Myeloperoxidase and its contributory role in inflammatory vascular disease.
Denise Lau (2006)
A Systematic Review of Dynamic Cerebral and Peripheral Endothelial Function in Lacunar Stroke Versus Controls
Susan F Stevenson (2010)
Myeloperoxidase deficiency preserves vasomotor function in humans
Tanja Katharina Rudolph (2012)
Incomplete lacunar infarction (Type I b lacunes)
G. Alistair Lammie (1998)
SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap
A. Johnson (2008)
Effect of pravastatin on cerebral infarcts and white matter lesions
Valerie H ten Dam (2005)
versus controls
VH tenDam (2010)
A population-based study of the incidence and prognosis of lacunar stroke
Simona Sacco (2006)
Epidemiology of stroke and its subtypes in Chinese vs white populations
C-F Tsai (2013)
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Joanna M. Wardlaw (2013)
Stroke Genetics Network (SiGN) Study: Design and Rationale for a Genome-Wide Association Study of Ischemic Stroke Subtypes
J. Meschia (2013)
Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis.
Charlie S. Thompson (2009)
Inflammatory Biomarkers of Vascular Risk as Correlates of Leukoariosis
Clinton B Wright (2009)
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.
Oscar R. Benavente (2012)
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
Marijn C. Meuwese (2007)
Meta-analysis methods for genome-wide association studies and beyond
Evangelos Evangelou (2013)
Classification of Subtype of Acute Ischemic Stroke Definitions for Use in a Multicenter Clinical Trial
Timothy S. Carter (2005)
Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.
Alexander P. Reiner (2013)
Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage.
D. Woo (2014)
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Joseph A. Vita (2004)
The Blood-Brain Barrier/Neurovascular Unit in Health and Disease
Brian T Hawkins (2005)
Brain-immune interactions and ischemic stroke: clinical implications.
Hooman Kamel (2012)
Genetic variation at 16q24.2 is associated with small vessel stroke
M. Traylor (2017)
Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease.
Joanna Pawlus (2010)
Myeloperoxidase, modified lipoproteins, and atherogenesis Published, JLR Papers in Press, December 16, 2008.
Stephen J Nicholls (2009)
APOE ε4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage
M. Raffeld (2015)
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage.
A. Biffi (2010)
Risk factor profile of cerebral small vessel disease and its subtypes
U. Khan (2007)
Oxidative stress in angiogenesis and vascular disease.
Y. Kim (2014)
Genetic variants in CETP increase risk of intracerebral hemorrhage
C. D. Anderson (2016)
Current Applications of Genetic Risk Scores to Cardiovascular Outcomes and Subclinical Phenotypes
Jennifer A. Smith (2015)
Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke
Matthew Traylor (2016)
Genotype Imputation with Thousands of Genomes
Bryan Howie (2011)
Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review
Anna Poggesi (2016)
Mendelian randomization: a new approach to studying epidemiology in ESRD.
Carmine Zoccali (2006)
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
Leonardo Pantoni (2010)
NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage.
Qingyi Ma (2014)
Inflammatory biomarkers, cerebral microbleeds, and small vessel disease
Ashkan Shoamanesh (2015)
Elevated serum myeloperoxidase activities are significantly associated with the prevalence of ACS and High LDL-C levels in CHD patients.
Chenggui Liu (2012)
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
A. Biffi (2015)
Intracerebral haemorrhage
A I Qureshi (2009)
Leukoaraiosis and dementia: To the editor
Tommaso Sacquegna (1990)
Genetics Network ( SiGN ) Study : design and rationale for a genome - wide association study of ischemic stroke sub - types
JF Meschia (2013)
Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease
C. Kaneski (2006)
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies
M. Traylor (2012)
Principal components analysis corrects for stratification in genome-wide association studies
Alkes L. Price (2006)
Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?
Joanna M Wardlaw (2003)
Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?
Shah Ebrahim (2007)
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Shaun M Purcell (2007)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar